Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients.
Azzopardi N, Lecomte T, Ternant D, Boisdron-Celle M, Piller F, Morel A, Gouilleux-Gruart V, Vignault-Desvignes C, Watier H, Gamelin E, Paintaud G.
Azzopardi N, et al.
Clin Cancer Res. 2011 Oct 1;17(19):6329-37. doi: 10.1158/1078-0432.CCR-11-1081. Epub 2011 Sep 27.
Clin Cancer Res. 2011.
PMID: 21953502
Clinical Trial.